Apolipoprotein C-III in patients with systemic lupus erythematosus

BACKGROUND: Systemic lupus erythematosus (SLE) has been associated with atherosclerotic cardiovascular disease (CV) and an altered lipid profile. High levels of apolipoprotein C-III (ApoC3) are associated with elevated triglyceride levels and an increased risk of CV. In the present study, we aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-González, Candelaria, Ferrer-Moure, Carmen, Carlos Quevedo-Abeledo, Juan, de Vera-González, Antonia, González-Delgado, Alejandra, Sánchez-Martín, Julio, González-Gay, Miguel Á., Ferraz-Amaro, Iván
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088095/
https://www.ncbi.nlm.nih.gov/pubmed/35538496
http://dx.doi.org/10.1186/s13075-022-02793-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088095/
https://www.ncbi.nlm.nih.gov/pubmed/35538496
http://dx.doi.org/10.1186/s13075-022-02793-y

Ejemplares similares